Role of nitric oxide in pathophysiology and treatment of pulmonary hypertension
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články
PubMed
25189396
DOI
10.1016/b978-0-12-800254-4.00016-7
PII: B978-0-12-800254-4.00016-7
Knihovny.cz E-zdroje
- Klíčová slova
- NO inhalation, Nitric oxide, Nitric oxide synthase, Pathophysiology, Pulmonary hypertension, Therapy,
- MeSH
- antihypertenziva farmakologie terapeutické užití MeSH
- lidé MeSH
- oxid dusnatý metabolismus MeSH
- plicní hypertenze farmakoterapie metabolismus patofyziologie MeSH
- synthasa oxidu dusnatého, typ III metabolismus MeSH
- vazodilatace fyziologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- antihypertenziva MeSH
- oxid dusnatý MeSH
- synthasa oxidu dusnatého, typ III MeSH
Pulmonary hypertension is a condition characterized by vasoconstriction, vascular cell proliferation, inflammation, microthrombosis, and vessel wall remodelation. Pulmonary endothelial cells produce vasoactive substances with vasoconstrictive as well as vasodilatative effects. The imbalance of these endothelium-derived vasoactive substances induced by endothelial dysfunction is very important in the pathogenesis of PH. One of most important substances with vasodilatative effect is nitric oxide. We provide a comprehensive insight into role of NO in the pathgenesis of PH and discuss perspectives and challenges in PH therapy based on NO administration.
Citace poskytuje Crossref.org